Associating antimicrobial susceptibility testing with clinical outcomes in cystic fibrosis: More rigor and less frequency?

J Cyst Fibros. 2019 Mar;18(2):159-160. doi: 10.1016/j.jcf.2019.02.008. Epub 2019 Feb 26.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Infective Agents*
  • Cystic Fibrosis*
  • Humans
  • Pseudomonas Infections*
  • Pseudomonas aeruginosa

Substances

  • Anti-Infective Agents